A systems biology approach to invasive behavior: Comparing cancer metastasis and suburban sprawl development

BMC Research Notes

Volumn 3, Issue , 2010, Pages

  Ryan, John J ^a   Dows, Benjamin L ^a   Kirk, Michael V ^a   Chen, Xueming ^a   Eastman, Jeffrey R ^b   Dyer, Rodney J ^a   Kier, Lemont B ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b Department of Community Development ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052976743     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-3-36     Document Type: Article

References (66)

1. Cancer Facts and Figures 2009. American Cancer Society, http://www.cancer.org
2. Mutation selection and the natural history of cancer. Cairns J, Nature 1975 255 5505 197 200 10.1038/255197a0 1143315
3. The clonal evolution of tumor cell populations. Nowell PC, Science 1976 194 4260 23 28 10.1126/science.959840 959840
4. Cancer as an evolutionary and ecological process. Merlo LM, Pepper JW, Reid BJ, Maley CC, Nat Rev Cancer 2006 6 12 924 935 10.1038/nrc2013 17109012 (Pubitemid 44862677)
5. Comparable ecological dynamics underlie early cancer invasion and species dispersal, involving self-organizing processes. Marco DE, Cannas SA, Montemurro MA, Hu B, Cheng SY, J Theor Biol 2009 256 1 65 75 10.1016/j.jtbi.2008.09.011 18930739
6. Fractal analysis of tumoral lesions in brain. Martin-Landrove M, Pereira D, Caldeira ME, Itriago S, Juliac M, Conf Proc IEEE Eng Med Biol Soc 2007 2007 1306 1309 18002203
7. Detection of prostate cancer from RF ultrasound echo signals using fractal analysis. Moradi M, Abolmaesumi P, Isotalo PA, Siemens DR, Sauerbrei EE, Mousavi P, Conf Proc IEEE Eng Med Biol Soc 2006 1 2400 2403 full text 17945712 (Pubitemid 46520390)
8. Nuclear fractal dimension as a prognostic factor in oral squamous cell carcinoma. Goutzanis L, Papadogeorgakis N, Pavlopoulos PM, Katti K, Petsinis V, Plochoras I, Pantelidaki C, Kavantzas N, Patsouris E, Alexandridis C, Oral Oncol 2008 44 4 345 353 10.1016/j.oraloncology.2007.04.005 17692559 (Pubitemid 351380979)
9. Fractal analysis of mammographic parenchymal patterns in breast cancer risk assessment. Li H, Giger ML, Olopade OI, Lan L, Acad Radiol 2007 14 5 513 521 10.1016/j.acra.2007.02.003 17434064 (Pubitemid 46551761)
10. 3-D fractal tumor growth of epithelial ovarian cancer. Kikuchi A, Kozuma S, Yasugi T, Taketani Y, Eur J Gynaecol Oncol 2006 27 6 561 565 17290583 (Pubitemid 46166250)
11. Simulating Sprawl. Torrens P, Annals of the Association of American Geographers 2006 96 2 248 275 10.1111/j.1467-8306.2006.00477.x (Pubitemid 44762307)
12. How important is tumour shape? Quantification of the epithelial- connective tissue interface in oral lesions using local connected fractal dimension analysis. Landini G, Rippin JW, J Pathol 1996 179 2 210 217 10.1002/(SICI)1096-9896(199606)179:2<210::AID-PATH560>3.0.CO;2-T 8758215
13. Fractal dimensions of the epithelial-connective tissue interfaces in premalignant and malignant epithelial lesions of the floor of the mouth. Landini G, Rippin JW, Anal Quant Cytol Histol 1993 15 2 144 149 8318129 (Pubitemid 23158938)
14. Predictive power of irregular border shapes for malignant melanomas. Lee TK, Claridge E, Skin Res Technol 2005 11 1 1 8 10.1111/j.1600-0846.2005.00076.x 15691253 (Pubitemid 40347602)
15. Fractal concepts in surface growth. Barabási A-L, Stanley HE, New York, NY, USA: Press Syndicate of the University of Cambridge 1995
16. Montemurro, Bo Hu, Shi-Yuan Cheng: Comparable ecological dynamics underlie early cancer invasion and species dispersal, involving self-organizing processes. Marco D, Cannas Sergio, Marcelo A, J Theor Biol 2009 256 1 65 75 10.1016/j.jtbi.2008.09.011 18930739
17. Fractal tumor growth of ovarian cancer: sonographic evaluation. Kikuchi A, Kozuma S, Sakamaki K, Saito M, Marumo G, Yasugi T, Taketani Y, Gynecol Oncol 2002 87 3 295 302 10.1006/gyno.2002.6842 12468328 (Pubitemid 36034650)
18. A toolkit for measuring sprawl. Torrens P, Applied Spatial Analysis 2008 1 5 36 10.1007/s12061-008-9000-x
19. Fractal cities: a geometry of form and function. Batty M, Longley P, London; San Diego: Academic Press 1994
20. Urban Malignancy: Similarity in the Fractal Dimensions of Urban Morphology and Malignant Neoplasms. Hern W, International Journal of Anthropology 2008 23 1-2 1 19
21. Suburban nation: the rise of sprawl and the decline of the American Dream. Duany A, Speck J, Plater-Zyberk E, New York: North Point Press 1 2000
22. Two genetic hits (more or less) to cancer. Knudson AG, Nat Rev Cancer 2001 1 2 157 162 10.1038/35101031 11905807 (Pubitemid 33741891)
23. Surfing the p53 network. Vogelstein B, Lane D, Levine AJ, Nature 2000 408 6810 307 310 10.1038/35042675 11099028
24. The RB and p53 pathways in cancer. Sherr CJ, McCormick F, Cancer Cell 2002 2 2 103 112 10.1016/S1535-6108(02)00102-2 12204530 (Pubitemid 41039110)
25. Cancer. Gleevec, chapter two: new leukemia drug aims to overcome resistance. Travis J, Science 2004 305 5682 319 321 10.1126/science.305.5682. 319a 15256643 (Pubitemid 38938126)
26. Tamoxifen in breast cancer: not so easy to write off. Munshi A, Singh P, Breast 2008 17 2 121 124 10.1016/j.breast.2007.08.010 17923407 (Pubitemid 351467954)
27. Towards third generation matrix metalloproteinase inhibitors for cancer therapy. Overall CM, Kleifeld O, Br J Cancer 2006 94 7 941 946 10.1038/sj.bjc.6603043 16538215
28. An orally delivered small-molecule formulation with antiangiogenic and anticancer activity. Benny O, Fainaru O, Adini A, Cassiola F, Bazinet L, Adini I, Pravda E, Nahmias Y, Koirala S, Corfas G, et al. Nat Biotechnol 2008 26 7 799 807 10.1038/nbt1415 18587385 (Pubitemid 351961454)
29. Induction of genetic instability by gain-of-function p53 cancer mutants. Xu Y, Oncogene 2008 27 25 3501 3507 10.1038/sj.onc.1211023 18223686 (Pubitemid 351793802)
30. Suburban Nation. Duany A, Plater-Zyberk Elizabeth, Speck Jeff, New York: North Point Press 2000
31. Crabgrass Frontier: The Suburbanization of the United States. Jackson K, New York: Oxford University Press 1985
32. The next slum? Leinberger C, The Atlantic Monthly 2008 301 2 70 75
33. Are Portland's smart Growth Policies Related to Reduced Automobile Dependence? Jun MJ, Journal of Planning Education and Research 2008 28 100 107 10.1177/0739456X08319240
34. Portland: Urban Growth Boundary Keeps Out Growth. Demographia, 2009 http://www.demographia.com/db-porugbmigr.pdf
35. Treatment of HER2-positive metastatic breast cancer following initial progression. Mayer IA, Clin Breast Cancer 2009 9 Suppl 2 50 57 10.3816/CBC.2009.s.005 19596643
36. Gasoline consumption and cities: a comparison of U.S. cities with a global survey. Kenworthy PNaJ, Journal of the American Planning Association 1989 55 1 24 37 10.1080/01944368908975398
37. Transit villages in the 21st century. Bernick M, Cervero R, New York; London: McGraw-Hill 1997
38. Urban structure matters: residential location, car dependence and travel behaviour. Næss P, London; New York: Routledge 2006
39. Are compact cities a desirable planning goal? Richardson PGaHW, Journal of the American Planning Association 1997 63 1 95 106 10.1080/01944369708975727
40. Asphalt Nation: How the Automobile Took Over America, and How We Can Take it back. Kay JH, New York: Crown 1997
41. The Elephant in the Bedroom: Automobile Dependence and Denial; Impacts on the Economy and Environment. Hart SaAS, Pasadena, Cailfornia: Paradigm Books 1993
42. Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. Eyler CE, Rich JN, J Clin Oncol 2008 26 17 2839 2845 10.1200/JCO.2007.15.1829 18539962
43. The Geography of Nowhere. Kunstler JH, New York: Simon and Schuster 1993
44. Timeline: Chemotherapy and the war on cancer. Chabner BA, Roberts TG Jr, Nat Rev Cancer 2005 5 1 65 72 10.1038/nrc1529 15630416 (Pubitemid 40052326)
45. Evolution of decitabine development: accomplishments, ongoing investigations, and future strategies. Jabbour E, Issa JP, Garcia-Manero G, Kantarjian H, Cancer 2008 112 11 2341 2351 10.1002/cncr.23463 18398832
46. A framework for understanding conservation development and its ecological implications. Milder J, Bio Science 2007 57 9 757 768 (Pubitemid 47612102)
47. A Landsat Surface Reflectance Dataset for North America, 1990-2000. Masek EFV Jeffrey G, Saleous Nazmi E, Wolfe Robert, Hall Forrest G, Huemmrich Karl F, Gao Feng, Kutler Jonathan, Lim Teng-Kui, IEEE GEOSCIENCE AND REMOTE SENSING LETTERS 2006 3 1 68 72 10.1109/LGRS.2005.857030 (Pubitemid 43131899)
48. Angiogenesis. Folkman J, Annu Rev Med 2006 57 1 18 10.1146/annurev.med. 57.121304.131306 16409133 (Pubitemid 43261975)
49. Smart Growth Techniques and Stratagies. http://www.smartgrowthplanning. org/Techniques.html#Contextsensitivestreetdesign
50. Cytokines and cancer anorexia cachexia syndrome. Bennani-Baiti N, Davis MP, Am J Hosp Palliat Care 2008 25 5 407 411 10.1177/1049909108315518 18403577
51. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO Jr, Engstrom PF, Ezdinli EZ, et al. Am J Med 1980 69 4 491 497 10.1016/S0149-2918(05)80001-3 7424938 (Pubitemid 10018703)
52. Prognostic factors in advanced gastrointestinal cancer patients with weight loss. O'Gorman P, McMillan DC, McArdle CS, Nutr Cancer 2000 37 1 36 40 10.1207/S15327914NC37014 10965517 (Pubitemid 30650664)
53. Nutrition in Cancer Care, National Cancer Institute. http://www.cancer. gov/cancertopics/pdq/supportivecare/nutrition/HealthProfessional/page2
54. Mechanisms mediating cancer cachexia. Toomey D, Redmond HP, Bouchier-Hayes D, Cancer 1995 76 12 2418 2426 10.1002/1097-0142(19951215)76: 12<2418::AID-CNCR2820761204>3.0.CO;2-C 8625066
55. Cancer cachexia: pathophysiologic aspects and treatment options. Topkan E, Yavuz AA, Ozyilkan O, Asian Pac J Cancer Prev 2007 8 3 445 451 18159985
56. Infection-control interventions for cancer patients after chemotherapy: a systematic review and meta-analysis. Schlesinger A, Paul M, Gafter-Gvili A, Rubinovitch B, Leibovici L, Lancet Infect Dis 2009 9 2 97 107 10.1016/S1473-3099(08)70284-6 19095499
57. Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002 - Medical Research Council Adult Leukaemia Working Party. Augustson BM, Begum G, Dunn JA, Barth NJ, Davies F, Morgan G, Behrens J, Smith A, Child JA, Drayson MT, J Clin Oncol 2005 23 36 9219 9226 10.1200/JCO.2005.03.2086 16275935
58. The role of infection in the morbidity and mortality of patients with head and neck cancer undergoing multimodality therapy. Hussain M, Kish JA, Crane L, Uwayda A, Cummings G, Ensley JF, Tapazoglou E, al-Sarraf M, Cancer 1991 67 3 716 721 10.1002/1097-0142(19910201)67:3<716::AID-CNCR2820670331>3.0.CO;2- J 1985764
59. [The cause of infection as the main or additional cause of death in patients treated for small cell lung cancer]. Remiszewski P, Slodkowska J, Szczepek B, Zwolska Z, Radomski P, Byszewska D, Rowinska-Zakrzewska E, Pneumonol Alergol Pol 1999 67 7-8 354 361 10647287
60. The Police and Neighborhood Safety: Broken Windows. Wilson JQ, Kelling George L, The Atlantic Monthly 1982 249 3 29 41
61. Active projects report from the Community Redevlopment Agency of the City of Los Angeles (CRA/LA). http://www.crala.org
62. The Spreading of Disorder10.1126/science.1161405. Keizer K, Lindenberg S, Steg L, Science 2008 1161405
63. A 2009 update on the treatment of patients with hormone receptor-positive breast cancer. Cleator SJ, Ahamed E, Coombes RC, Palmieri C, Clin Breast Cancer 2009 9 Suppl 1 6 S17 10.3816/CBC.2009.s.001 19561006
64. HER-2 signaling and inhibition in breast cancer. Browne BC, O'Brien N, Duffy MJ, Crown J, O'Donovan N, Curr Cancer Drug Targets 2009 9 3 419 438 10.2174/156800909788166484 19442060
65. Waste management-cytokines, growth factors and cachexia. Saini A, Al-Shanti N, Stewart CE, Cytokine Growth Factor Rev 2006 17 6 475 486 10.1016/j.cytogfr.2006.09.006 17118696 (Pubitemid 44793120)
66. Cell motility of tumor cells visualized in living intact primary tumors using green fluorescent protein. Farina KL, Wyckoff JB, Rivera J, Lee H, Segall JE, Condeelis JS, Jones JG, Cancer Res 1998 58 12 2528 2532 9635573 (Pubitemid 28275420)